Molecular Attraction AB
Gustav Notander is an experienced professional with a background in biotechnology, holding a Master of Science in Engineering from the Royal Institute of Technology. Notander currently serves as a Member of the Board of Directors for multiple companies, including Molecular Attraction AB, Geras Solutions, TIRmed Pharma, Epigenica, TERASi, UTIlizer AB, Developeration AB, Medituner AB, and Resitu Medical AB, each focusing on innovative technologies in life sciences, healthcare, and environmental solutions. Additionally, Notander works as an Investment Manager at Almi Invest, specializing in early-stage science and technology-based startups.
This person is not in the org chart
This person is not in any teams
Molecular Attraction AB
Molecular Attraction technology enable development of vector-diseases control and eradication strategies. We are a bio-attractant discovery company. We identify biological compounds which can change behaviour of vectors organisms like mosquitoes, flies or rodents. Molecular Attraction compounds includes: Volatile attractants Phagostimulants Pheromones Molecular Attraction is a biotechnology company anchored in high-end research stemming from Stockholm University. Our competence: Biochemical compound identification Insect behaviour Parasitic infections biochemistry and immunology